Joint Meeting with Antibodies as Drugs
Organizers: Danica Stanimirovic (in memoriam)James GormanStina Syvänen
Supported by Directors’ Fund
Better treatments are urgently needed for a range of devastating brain diseases, including prevalent neurodegenerative diseases, brain tumors and metastases, and rare genetic conditions. One major challenge in development of experimental CNS disease therapies is the lack of efficient tailored strategies for their delivery to the brain and spinal cord. This is the only conference to focuses entirely on scientific and technological advances and challenges in delivering new therapies, across a wide range of modalities, to appropriate compartments in the CNS.
For more information: https://www.keystonesymposia.org/conferences/conference-listing/meeting?eventid=7088